You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells

 

Online download statistics by month:

Online download statistics by month: December 2019 to December 2025

AbstractFullPdf
Dec 2019440
Jan 202029291
Feb 202043431
Mar 202060603
Apr 202052526
May 202057577
Jun 202034348
Jul 202024248
Aug 202038384
Sep 2020313112
Oct 2020333326
Nov 202016169
Dec 2020202013
Jan 2021434314
Feb 2021222216
Mar 2021262624
Apr 2021373821
May 2021282825
Jun 2021323216
Jul 2021323222
Aug 2021272715
Sep 2021343324
Oct 2021313127
Nov 2021293031
Dec 2021353622
Jan 2022272913
Feb 2022445028
Mar 2022333728
Apr 2022252614
May 2022464725
Jun 2022505415
Jul 202226264
Aug 2022444416
Sep 2022313519
Oct 2022333311
Nov 2022303019
Dec 202224244
Jan 2023404324
Feb 202333349
Mar 2023525424
Apr 2023242623
May 202320217
Jun 2023242416
Jul 2023343412
Aug 2023303110
Sep 2023363714
Oct 202314214216
Nov 202341441411
Dec 202317317325
Jan 202410810863
Feb 2024676819
Mar 2024444717
Apr 202440428
May 2024505111
Jun 2024353516
Jul 2024434418
Aug 2024505220
Sep 2024272723
Oct 2024333322
Nov 2024313222
Dec 2024727324
Jan 2025494937
Feb 2025454524
Mar 2025535334
Apr 2025646417
May 2025302917
Jun 2025303119
Dec 2025100
Total312431701153